Results 31 to 40 of about 58,031 (256)

Targeted radiotherapy of neuroblastoma: future directions [PDF]

open access: yes, 2017
No abstract ...
Gaze, Mark N.   +4 more
core   +2 more sources

Advances in targeted Alpha therapy for prostate cancer [PDF]

open access: yes, 2019
BACKGROUND: Amongst therapeutic radiopharmaceuticals, targeted alpha therapy (TαT) can deliver potent and local radiation selectively to cancer cells as well as the tumor microenvironment and thereby control cancer while minimizing toxicity.
De Vincentis, G   +11 more
core   +2 more sources

Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics [PDF]

open access: yes, 2019
Androgen ablating drugs increase life expectancy in men with metastatic prostate cancer, but resistance inevitably develops. In a majority of these recurrent tumors, the androgen axis is reactivated in the form of increased androgen receptor (AR ...
Beattie, Bradley J.   +10 more
core   +2 more sources

Analysis of lncRNA and mRNA Transcriptomes Expression in Thyroid Cancer Tissues Among Patients With Exposure of Medical Occupational Radiation

open access: yesDose-Response, 2019
Background: Occupational exposure of radiation among medical radiation workers contributes to the subsequent increased risk of thyroid cancer. Long noncoding RNAs (lncRNAs) are emerging as important regulators of cancer biology.
Feng Shi   +6 more
doaj   +1 more source

Radionuclide Therapy of Bone Metastases [PDF]

open access: yesBreast Care, 2012
The skeleton is a potential metastatic target of many malignant tumors. Up to 85% of prostate and breast cancer patients may develop bone metastases causing severe pain syndromes in many of them. In patients suffering from multilocular, mainly osteoblastic lesions and pain syndrome, radionuclide therapy is recommended for pain palliation.
Manfred Fischer, Willm U. Kampen
openaire   +3 more sources

Novel multifunctional 90Y-labelled albumin magnetic microspheres for cancer therapy [PDF]

open access: yesJ. Mater. Chem., 2012,22, 24017-24025, 2012
We present in vitro and in vivo studies of yttrium-90 (90Y)-labelled human serum albumin magnetic microspheres (HSAMMS) as multifunctional agent for bimodal radionuclide-hyperthermia cancer therapy. The HSAMMS were produced using a modified emulsification-heat stabilization technique and contained 10-nm magnetite nanoparticles coated with citric acid ...
arxiv   +1 more source

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors [PDF]

open access: yes, 2017
Background Patients with advanced midgut neuroendocrine tumors who have had disease progression during first-line somatostatin analogue therapy have limited therapeutic options.
Al‐nahhas, A   +82 more
core   +1 more source

PERSONALIZED APPROACH TO THYROTOXICOSIS TREATMENT: THE HISTORY OF DOSIMETRIC CONCEPTS DEVELOPMENT

open access: yesВестник рентгенологии и радиологии, 2017
In recent decade, nuclear medicine demonstrates a tendency towards improvement of dosimetry approaches to radionuclide therapy. Historically there were developed several methods for calculating effective therapeutic activity: prescription of standard ...
P. O. Rumyantsev   +2 more
doaj   +1 more source

Continuing Nuclear Data Research for Production of Accelerator-Based Novel Radionuclides for Medical Use: A Mini-Review

open access: yesFrontiers in Physics, 2021
Nuclear data are important for production and medical application of a radionuclide. This brief review concentrates on nuclear reaction cross-section data.
Syed M. Qaim   +3 more
doaj   +1 more source

Treatment of a mixed acinar-endocrine carcinoma with uptake on 68Gallium-DOTATOC positron emission tomography-computed tomography : a case report [PDF]

open access: yes, 2017
The case of a 35-year old female patient with a diagnosis of metastatic mixed acinar-endocrine carcinoma (MAEC) is investigated in the present study.
De Both, Anneleen   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy